First Dallas Securities’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
First Dallas Securities's NVO Position: Q3 2026 in Review
First Dallas Securities reduced its Novo Nordisk (NVO) stake by 43% in Q3 2026, selling an estimated $417K and leaving 11,920 shares worth $452K. The position accounts for 0.15% of the portfolio, ranked #93.
First Dallas Securities first reported a position in NVO in Q4 2022 and has held it in 11 quarters since. The position peaked at $2.63M in Q3 2023. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- First Dallas Securities held 11,920 shares of Novo Nordisk worth $452K as of Q3 2026.
- First Dallas Securities sold 9,047 Novo Nordisk shares in Q3 2026, an estimated $417K.
- Novo Nordisk made up 0.15% of First Dallas Securities's portfolio in Q3 2026, its #93 holding.
- First Dallas Securities first reported a position in Novo Nordisk in Q4 2022 and has held it in 11 quarters since.
- First Dallas Securities's Novo Nordisk position peaked at $2.63M in Q3 2023.
- 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on First Dallas Securities's 13F filing for Q3 2026, filed 13 Nov 2026.